Merck (MRK) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Merck (MRK) over the last 16 years, with Q4 2024 value amounting to $19.2 billion.
- Merck's Accumulated Depreciation & Amortization rose 486.7% to $19.2 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $19.2 billion, marking a year-over-year increase of 486.7%. This contributed to the annual value of $19.2 billion for FY2024, which is 486.7% up from last year.
- As of Q4 2024, Merck's Accumulated Depreciation & Amortization stood at $19.2 billion, which was up 486.7% from $18.3 billion recorded in Q4 2023.
- In the past 5 years, Merck's Accumulated Depreciation & Amortization ranged from a high of $19.2 billion in Q4 2024 and a low of $150.0 million during Q4 2020
- In the last 5 years, Merck's Accumulated Depreciation & Amortization had a median value of $362.5 million in 2020 and averaged $4.2 billion.
- Per our database at Business Quant, Merck's Accumulated Depreciation & Amortization tumbled by 8038.48% in 2020 and then surged by 993626.37% in 2023.
- Quarter analysis of 5 years shows Merck's Accumulated Depreciation & Amortization stood at $150.0 million in 2020, then grew by 9.33% to $164.0 million in 2021, then rose by 10.98% to $182.0 million in 2022, then surged by 9936.26% to $18.3 billion in 2023, then grew by 4.87% to $19.2 billion in 2024.
- Its Accumulated Depreciation & Amortization stands at $19.2 billion for Q4 2024, versus $18.3 billion for Q4 2023 and $182.0 million for Q4 2022.